Sanofi (NASDAQ:SNY) Shares Gap Down to $50.11

Sanofi (NASDAQ:SNY) gapped down before the market opened on Wednesday . The stock had previously closed at $50.11, but opened at $48.22. Sanofi shares last traded at $48.61, with a volume of 1,008,582 shares traded.

Sanofi Stock Performance

The company has a market capitalization of $121.77 billion, a P/E ratio of 24.16, a PEG ratio of 1.50 and a beta of 0.60. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. The company’s 50-day moving average is $48.59 and its two-hundred day moving average is $48.54.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, April 25th. The company reported $0.96 EPS for the quarter, meeting analysts’ consensus estimates of $0.96. The business had revenue of $11.36 billion for the quarter, compared to analysts’ expectations of $11.75 billion. Sanofi had a return on equity of 26.25% and a net margin of 10.52%. Equities analysts anticipate that Sanofi will post 4.13 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Old Port Advisors boosted its stake in shares of Sanofi by 4.6% during the first quarter. Old Port Advisors now owns 36,224 shares of the company’s stock valued at $1,761,000 after purchasing an additional 1,596 shares during the period. Boston Partners grew its holdings in Sanofi by 0.3% in the 1st quarter. Boston Partners now owns 13,066,403 shares of the company’s stock worth $635,280,000 after acquiring an additional 33,657 shares during the last quarter. Teachers Retirement System of The State of Kentucky increased its position in shares of Sanofi by 55.6% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 309,960 shares of the company’s stock valued at $15,064,000 after acquiring an additional 110,800 shares during the period. Cetera Advisors LLC raised its stake in shares of Sanofi by 301.6% during the first quarter. Cetera Advisors LLC now owns 60,359 shares of the company’s stock valued at $2,933,000 after acquiring an additional 45,330 shares during the last quarter. Finally, Cetera Investment Advisers grew its stake in shares of Sanofi by 245.4% in the first quarter. Cetera Investment Advisers now owns 178,349 shares of the company’s stock worth $8,668,000 after purchasing an additional 126,712 shares during the last quarter. Hedge funds and other institutional investors own 10.04% of the company’s stock.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.